These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 574057)
1. Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients. Merrin CE Cancer Treat Rep; 1979; 63(9-10):1579-84. PubMed ID: 574057 [No Abstract] [Full Text] [Related]
2. Phase II trials with cis-dichlorodiammineplatinum(II) in the treatment of urothelial cancer. Yagoda A Cancer Treat Rep; 1979; 63(9-10):1565-72. PubMed ID: 387226 [TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy of advanced genitourinary carcinoma with cis-diamminedichloroplatinum]. Uchida T; Kobayashi K; Arakawa T; Omata T; Li K; Ikeda S; Endo T; Ishibashi A; Koshiba K Hinyokika Kiyo; 1984 Sep; 30(9):1173-83. PubMed ID: 6084421 [TBL] [Abstract][Full Text] [Related]
6. The role of chemotherapy in the management of malignant urogenital neoplasms. Schnipper LE Urol Clin North Am; 1976 Jun; 3(2):423-32. PubMed ID: 960317 [No Abstract] [Full Text] [Related]
7. [Phase II study of cis-diamminedichloroplatinum (II) in genitourinary cancer]. Gan To Kagaku Ryoho; 1982 Mar; 9(3):433-42. PubMed ID: 6764107 [TBL] [Abstract][Full Text] [Related]
8. [Phase II study on cis-diamminedichloroplatinum (II) by a collaborative study]. Gan To Kagaku Ryoho; 1982 Jan; 9(1):46-54. PubMed ID: 6892191 [TBL] [Abstract][Full Text] [Related]
9. A review of therapeutic strategies for phase I-II trials in genitourinary cancer. Friedman MA Recent Results Cancer Res; 1980; 70():203-10. PubMed ID: 7188814 [No Abstract] [Full Text] [Related]
10. Chemotherapy of genitourinary malignancies. Gordon RL Semin Drug Treat; 1973; 3(1):69-72. PubMed ID: 4123696 [No Abstract] [Full Text] [Related]
12. Phase II evaluation of cis-dichlorodiammineplatinum(II) in advanced malignancies of the genitourinary and gynecologic organs: a Southwest Oncology Group Study. Rossof AH; Talley RW; Stephens R; Thigpen T; Samson MK; Groppe C; Eyre HJ; Fisher R Cancer Treat Rep; 1979; 63(9-10):1557-64. PubMed ID: 498155 [TBL] [Abstract][Full Text] [Related]
13. The role of cis-platinum in solid-tumor therapy. Einhorn LH; Williams SD N Engl J Med; 1979 Feb; 300(6):289-91. PubMed ID: 366407 [No Abstract] [Full Text] [Related]
14. [Experimental evaluation of cisplatin analogous in urogenital cancer]. Machida T; Akasaka Y Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1386-92. PubMed ID: 2658827 [TBL] [Abstract][Full Text] [Related]
16. [A study of combination chemotherapy with cis-diamminedichloroplatinum for advanced genitourinary carcinoma]. Nakatsu H; Nishimoto K; Moriyama H; Ehara S; Igawa M; Ishino T; Kodama M; Fujii M; Ukai R; Nihira H Gan To Kagaku Ryoho; 1982 Apr; 9(4):702-9. PubMed ID: 6892199 [TBL] [Abstract][Full Text] [Related]
18. [A new cytostatic agent: cis-dischlorodiamin platinum II (DDP)]. Gallmeier WM; Bruntsch U MMW Munch Med Wochenschr; 1979 May; 121(18):624-7. PubMed ID: 108586 [No Abstract] [Full Text] [Related]
19. [Guideline for proper use of antineoplastic agents. Urologic cancer]. Akaza H; Miyanaga N Gan To Kagaku Ryoho; 2002 Jun; 29(6):1055-64. PubMed ID: 12109446 [No Abstract] [Full Text] [Related]
20. Role of multidrug resistance in tumors of the genitourinary tract. Theyer G; Hamilton G Urology; 1994 Dec; 44(6):942-50. PubMed ID: 7985331 [No Abstract] [Full Text] [Related] [Next] [New Search]